Progress is being made to address the wide array of neurological disorders that impact nearly one-third of Americans.
Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans according to new research. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.
With nearly 1,000 clinical trials in the state, a new study finds biopharma research supports 52,000 jobs in Tennessee and ads $11.7 billion to the economy.
Recently, the ACC and AHA lowered the definition of hypertension and did away with the term 'prehypertension' in an effort to start interventions earlier.
On Nov. 13, the Nashville Health Care Council hosted a panel discussion on collaborations between the pharmaceutical and healthcare provider sectors and how those collaborations can drive change in healthcare.
A 10-year study, led by Vanderbilt University Medical Center professor of Obstetrics and Gynecology Katherine Hartmann, MD, PhD, disrupts conventional wisdom that uterine fibroids cause miscarriages.
Richard Shelton, MD, is on a mission to bring the latest medical breakthroughs to mental health patients faster than ever.
Through the new Vanderbilt Center for Addiction Research (VCAR), researchers from diverse scientific disciplines are joining forces to define the molecular events that drive addictive behavior and ultimately to develop new treatments that can help people sustain long-term recovery.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: